abstract |
This disclosure relates to compounds that are useful for modulating the expression of apolipoprotein A-I (ApoA-I) and their use in the treatment and prevention of cardiovascular disease and related disease states, including cholesterol-related ones. or lipid disorders, such as atherosclerosis, for example. |